CNCT19 cell injection

BIOLOGICAL2 trials

Sponsors

Peking Union Medical College Hospital, Juventas Cell Therapy Ltd.

Conditions

Immune ThrombocytopeniaLupus NephritisNeurological Autoimmune DiseasesRefractory Systemic Lupus Erythematosus

Early Phase 1

CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus

Peking Union Medical College HospitalImmune Thrombocytopenia, Lupus Nephritis, Refractory Systemic Lupus Erythematosus

Start: 2023-06-19End: 2025-05-30Target: 12Updated: 2023-07-05

A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

RecruitingNCT07275736

Juventas Cell Therapy Ltd.Neurological Autoimmune Diseases

Start: 2025-03-01End: 2029-06-01Target: 18Updated: 2026-03-05